122 related articles for article (PubMed ID: 35798387)
21. Current Understanding of the Intestinal Absorption of Nucleobases and Analogs.
Yuasa H; Yasujima T; Inoue K
Biol Pharm Bull; 2020; 43(9):1293-1300. PubMed ID: 32879202
[TBL] [Abstract][Full Text] [Related]
22. Hypoxanthine uptake by skeletal muscle microvascular endothelial cells from equilibrative nucleoside transporter 1 (ENT1)-null mice: effect of oxidative stress.
Bone DB; Antic M; Quinonez D; Hammond JR
Microvasc Res; 2015 Mar; 98():16-22. PubMed ID: 25448155
[TBL] [Abstract][Full Text] [Related]
23. APEX1 Polymorphism and Mercaptopurine-Related Early Onset Neutropenia in Pediatric Acute Lymphoblastic Leukemia.
Kim H; Seo H; Park Y; Min BJ; Seo ME; Park KD; Shin HY; Kim JH; Kang HJ
Cancer Res Treat; 2018 Jul; 50(3):823-834. PubMed ID: 28882023
[TBL] [Abstract][Full Text] [Related]
24. Mechanistic mathematical modelling of mercaptopurine effects on cell cycle of human acute lymphoblastic leukaemia cells.
Panetta JC; Evans WE; Cheok MH
Br J Cancer; 2006 Jan; 94(1):93-100. PubMed ID: 16333308
[TBL] [Abstract][Full Text] [Related]
25. Slc43a3 is a regulator of free fatty acid flux.
Hasbargen KB; Shen WJ; Zhang Y; Hou X; Wang W; Shuo Q; Bernlohr DA; Azhar S; Kraemer FB
J Lipid Res; 2020 May; 61(5):734-745. PubMed ID: 32217606
[TBL] [Abstract][Full Text] [Related]
26. The course of biological parameters and 6-mercaptopurine pharmacokinetics during maintenance treatment of children with acute lymphoblastic leukaemia.
Hayder S; Björk O; Lafolie P
Acta Paediatr Scand; 1990; 79(8-9):832-7. PubMed ID: 2239280
[TBL] [Abstract][Full Text] [Related]
27. Thioguanine versus mercaptopurine for therapy of childhood lymphoblastic leukaemia: a comparison of haematological toxicity and drug metabolite concentrations.
Lancaster DL; Lennard L; Rowland K; Vora AJ; Lilleyman JS
Br J Haematol; 1998 Jul; 102(2):439-43. PubMed ID: 9695957
[TBL] [Abstract][Full Text] [Related]
28. Mercaptopurine in childhood leukaemia: the effects of dose escalation on thioguanine nucleotide metabolites.
Lennard L; Welch J; Lilleyman JS
Br J Clin Pharmacol; 1996 Oct; 42(4):525-7. PubMed ID: 8904630
[TBL] [Abstract][Full Text] [Related]
29. Molecular Basis of Nucleobase Transport Systems in Mammals.
Inoue K
Biol Pharm Bull; 2017; 40(8):1130-1138. PubMed ID: 28768993
[TBL] [Abstract][Full Text] [Related]
30.
Fan POL; Leung KT; Chan KYY; Leung AWK; Lam GKS; Chow TTW; Cheng FWT; Yuen LYP; Moriyama T; Yang JJ; Li CK
Pediatr Hematol Oncol; 2022 Apr; 39(3):254-266. PubMed ID: 34665987
[TBL] [Abstract][Full Text] [Related]
31. Specific MRP4 Inhibitor Ceefourin-1 Enhances Apoptosis Induced by 6-Mercaptopurine in Jurkat Leukemic Cells, but Not in Normal Lymphoblast Cell Line CRL-1991.
Becerra E; Berumen L; Soto-Ontiveros V; García-Alcocer G
Medicina (Kaunas); 2022 May; 58(6):. PubMed ID: 35743958
[No Abstract] [Full Text] [Related]
32. Precision therapy of 6-mercaptopurine in Chinese children with acute lymphoblastic leukaemia.
Zhou Y; Wang L; Zhai XY; Wen L; Tang F; Yang F; Liu XT; Dong L; Zhi LJ; Shi HY; Hao GX; Zheng Y; Jacqz-Aigrain E; Wang TY; Zhao W
Br J Clin Pharmacol; 2020 Aug; 86(8):1519-1527. PubMed ID: 32077136
[TBL] [Abstract][Full Text] [Related]
33. Pharmacologic Inhibition of NT5C2 Reverses Genetic and Nongenetic Drivers of 6-MP Resistance in Acute Lymphoblastic Leukemia.
Reglero C; Dieck CL; Zask A; Forouhar F; Laurent AP; Lin WW; Albero R; Miller HI; Ma C; Gastier-Foster JM; Loh ML; Tong L; Stockwell BR; Palomero T; Ferrando AA
Cancer Discov; 2022 Nov; 12(11):2646-2665. PubMed ID: 35984649
[TBL] [Abstract][Full Text] [Related]
34. Antagonism by methotrexate on mercaptopurine disposition in lymphoblasts during up-front treatment of acute lymphoblastic leukemia.
Dervieux T; Hancock ML; Pui CH; Rivera GK; Sandlund JT; Ribeiro RC; Boyett J; Evans WE; Relling MV
Clin Pharmacol Ther; 2003 Jun; 73(6):506-16. PubMed ID: 12811360
[TBL] [Abstract][Full Text] [Related]
35. Continuing therapy for childhood acute lymphoblastic leukaemia: clinical and cellular pharmacology of methotrexate, 6-mercaptopurine and 6-thioguanine.
Estlin EJ
Cancer Treat Rev; 2001 Dec; 27(6):351-63. PubMed ID: 11908928
[TBL] [Abstract][Full Text] [Related]
36. The interaction of 6-mercaptopurine (6-MP) and methotrexate (MTX).
Giverhaug T; Loennechen T; Aarbakke J
Gen Pharmacol; 1999 Oct; 33(4):341-6. PubMed ID: 10523073
[TBL] [Abstract][Full Text] [Related]
37. The Role of TPMT, ITPA, and NUDT15 Variants during Mercaptopurine Treatment of Swedish Pediatric Patients with Acute Lymphoblastic Leukemia.
Wahlund M; Nilsson A; Kahlin AZ; Broliden K; Myrberg IH; Appell ML; Berggren A
J Pediatr; 2020 Jan; 216():150-157.e1. PubMed ID: 31635813
[TBL] [Abstract][Full Text] [Related]
38. Pharmacogenetic evaluation of 6-mercaptopurine-mediated toxicity in pediatric acute lymphoblastic leukemia patients from a South Indian population.
Ramalingam R; Kaur H; Scott JX; Sneha LM; Arun Kumar GP; Srinivasan A; Paul SF
Pharmacogenomics; 2021 May; 22(7):401-411. PubMed ID: 33876659
[No Abstract] [Full Text] [Related]
39. Desulfuration of 6-mercaptopurine. The basis for the paradoxical cytotoxicity of thiopurines in cultured human leukemic cells.
Adamson PC; Balis FM; Hawkins ME; Murphy RF; Poplack DG
Biochem Pharmacol; 1993 Nov; 46(9):1627-36. PubMed ID: 8240420
[TBL] [Abstract][Full Text] [Related]
40. Frequency of ITPA gene polymorphisms in Iranian patients with acute lymphoblastic leukemia and prediction of its myelosuppressive effects.
Azimi F; Mortazavi Y; Alavi S; Khalili M; Ramazani A
Leuk Res; 2015 Oct; 39(10):1048-54. PubMed ID: 26242828
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]